Publication | Closed Access
U.K. consensus statement on safe clinical prescribing of bexarotene for patients with cutaneous T-cell lymphoma
101
Citations
25
References
2012
Year
Clinical prescribing of bexarotene for patients with CTCL requires careful monitoring to allow safe administration of bexarotene at the optimal dose.
| Year | Citations | |
|---|---|---|
Page 1
Page 1